DOCSLIB.ORG

Targeting Ion Channels in Cancer: a Novel Frontier in Antineoplastic Therapy A

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Targeting Ion Channels in Cancer: a Novel Frontier in Antineoplastic Therapy A 66 Current Medicinal Chemistry, 2009, 16, 66-93 Targeting Ion Channels in Cancer: A Novel Frontier in Antineoplastic Therapy A. Arcangeli*,1, O. Crociani1, E. Lastraioli1, A. Masi1, S. Pillozzi1 and A. Becchetti2 1Department of Experimental Pathology and Oncology, University of Firenze, Italy; 2Department of Biotechnology and Biosciences, University of Milano-Bicocca, Italy Abstract: Targeted therapy is considerably changing the treatment and prognosis of cancer. Progressive understanding of the molecular mechanisms that regulate the establishment and progression of different tumors is leading to ever more spe- cific and efficacious pharmacological approaches. In this picture, ion channels represent an unexpected, but very promising, player. The expression and activity of different channel types mark and regulate specific stages of cancer progression. Their contribution to the neoplastic phenotype ranges from control of cell proliferation and apoptosis, to regulation of invasiveness and metastatic spread. As is being in- creasingly recognized, some of these roles can be attributed to signaling mechanisms independent of ion flow. Evidence is particularly extensive for K+ channels. Their expression is altered in many primary human cancers, especially in early stages, and they frequently exert pleiotropic effects on the neoplastic cell physiology. For instance, by regulating membrane potential they can control Ca2+ fluxes and thus the cell cycle machinery. Their effects on mitosis can also de- pend on regulation of cell volume, usually in cooperation with chloride channels. However, ion channels are also impli- cated in late neoplastic stages, by stimulating angiogenesis, mediating the cell-matrix interaction and regulating cell motil- ity. Not surprisingly, the mechanisms of these effects are manifold. For example, intracellular signaling cascades can be triggered when ion channels form protein complexes with other membrane proteins such as integrins or growth factor re- ceptors. Altered channel expression can be exploited for diagnostic purposes or for addressing traceable or cytotoxic compounds to specific neoplastic tissue. What is more, recent evidence indicates that blocking channel activity impairs the growth of some tumors, both in vitro and in vivo. This opens a new field for medicinal chemistry studies, which can avail of the many available tools, such as blocking antibodies, antisense oligonucleotides, small interfering RNAs, peptide toxins and a large variety of small organic compounds. The major drawback of this approach is that some ion channel blockers pro- duce serious side effects, such as cardiac arrhythmias. Therefore, drug developing efforts aimed at producing less harmful compounds are needed and we discuss possible approaches toward this goal. Finally, we propose that a novel therapeutic tactic could be developed by unlocking ion channels from multiprotein membrane signaling complexes. Keywords: Leukemia, glioma, breast cancer, colorectal cancer, prostate cancer, ion channels, Kv 1.3, KCa 3.1, hEAG-1, Kv 10.1, hERG1, Kv 11.1, Nav 1.5, Nav 1.7. 1. CURRENT VIEWS ON CANCER BIOLOGY AND The molecular dissection of neoplastic progression po- THERAPY tentially opens the way to the development of drugs address- ing tumor-specific processes. The many recent efforts de- The molecular biological revolution that has reshaped voted to this task have led to substantial improvement in biomedical research over the past three decades has also treatment. For instance, novel selective inhibitors of receptor changed dramatically our understanding of the origins of and non receptor tyrosine kinases, pivotal regulators of cell neoplasia. The main new notion is probably that cancer cells survival and proliferation, are now available for clinical use. are mutants. They often carry somatic mutations of tumor- An excellent example is the human Epidermal Growth Fac- related genes, although other modifications such as gene tor (EGF) receptor-2 (HER2). Herceptin, the therapeutic amplification or inactivation can also occur, possibly caused monoclonal antibody against HER2 approved by the Food by epigenetic mechanisms. The systematic search for genes and Drug Administration, has been used to treat over particularly liable to mutate during tumour progression has 150,000 women with breast cancer. Considerable advances led to the concept that cancer is a multistep process. Early have also been made in anti-angiogenesis therapy, because steps comprise alteration of a relatively small number of inhibitors of the Vascular Endothelial Growth Factors genes implicated in cell proliferation, apoptosis and differen- (VEGFs) and their receptors revert the tumor-associated tiation. As a consequence, cell clones are produced which are blood vessels to a quasi-normal state. Besides hampering cell invulnerable from apoptosis and capable of unlimited prolif- proliferation, this treatment allows chemotherapeutic drugs eration. The growing tumor mass then stimulates angiogene- to access the tumor’s core. By combining new specific sis, in order to sustain itself. At later stages, phenotypic fea- agents with traditional chemotherapy, patient survival is tures are selected that enable cells to invade and colonize often significantly prolonged. Although many questions still (metastasize) neighbouring or even distant tissue, and even- linger as to the choice of the best drug combination and tually to evade and overcome immune response [1]. regimen calibration, there is little doubt that targeted thera- pies are changing care and prognosis for the better [1]. Here, we review the growing experimental and preclini- *Address correspondence to this author at the Department of Experimental cal evidence indicating that ion channels should be included Pathology and Oncology, University of Firenze, Italy; Tel: +39 055 among the novel targets for cancer therapy, which may open 4598206; Fax: +39 055 4598900; E-mail: [email protected] 0929-8673/09 $55.00+.00 © 2009 Bentham Science Publishers Ltd. Targeting Ion Channels in Cancer Current Medicinal Chemistry, 2009 Vol. 16, No. 1 67 an entire pharmaceutical and clinical field. Why ion chan- the few pharmaceutically tractable molecular classes. A nels? First, their expression is often grossly altered in human major advantage is their accessibility from the extracellular cancers. Second, channel dysfunction can have a strong side, which makes ion channel modulators particularly effec- impact on cell physiology and signaling, with ensuing effects tive. on cancer progression. Third, ion channels represent one of Fig. (1). Dendrogram of the different families of K+ Channels, Voltage-Gated Ca2+ Channels (VGCC) and Voltage-Gated Na+ Chan- + + + nels (VGSC). For K Channels, the four main families are shown: Voltage-Gated K Channels (VGKC or Kv ), Inwardly-Rectifying K 2+ + + Channels (KIR), Ca -activated K Channels (KCa ) and Two-pore K Channels (K2p). Subtypes are named according to the IUPHAR nomen- clature. The channel types mainly expressed in cancer cells are highlighted. Box: comparison of IUPHAR, HGNC and common names for the K+ channels discussed in the text and tables. 68 Current Medicinal Chemistry, 2009 Vol. 16, No. 1 Arcangeli et al. 2. ION CHANNEL STRUCTURE AND PHYSIOLOGY: Finally, the Transient Receptor Potential (TRP) gene su- A BRIEF SURVEY perfamily is also related to the VGC’s, thus retaining the structural features outlined above. Subunits form homo- or Ion channels are integral membrane proteins that control heterotetrameric channels. Six TRP families are known passive ion fluxes, by switching between non conductive (TRPC, TRPV, TRPM, TRPA, TRPP and TRPML), with (‘closed’) and conductive (‘open’) conformational states. different permeability ratios between Ca2+ and monovalent Such a ‘gating’ process (activation) is often driven by trans- cations, ranging from nil to very high. These proteins are membrane voltage (Vm) or specific ligands, although other widely distributed in mammalian tissues and have been im- mechanisms are possible. Many types of ion channels exist, plicated in several human diseases, including cancer. The with widely different degrees of ion selectivity and kinetic physiological meaning of altered TRP channel expression in features, which produces great functional flexibility. Volt- tumors is under intense study [8]. age-gated channels (VGCs) usually regulate cellular excit- Fig. (1) shows a dendrogram of VGCs with the corre- ability and shape the action potential. In addition, by control- 2+ sponding IUPHAR nomenclature. Channels that have been ling transmembrane Ca fluxes, they can trigger exocytosis detected in cancer cells are highlighted. For the K+ channels and muscle contraction. Ligand-gated channels typically discussed in the text, both the IUPHAR and the common exert synaptic roles. The integrated action of different chan- nel types controls cell volume, transepithelial ion flow, sen- names are given (box). sory transduction, synaptic function and many other physio- The other side of the ion transport coin is constituted by logical processes. ion pumps and other transporters. Knowledge about the transporters’ role in neoplasia is however less extensive than If the stimulus is interrupted, channels close (deactiva- it is for ion channels. Therefore, we will limit our discussion tion). Otherwise, they often enter a further non conductive + + + state, by a process named inactivation for voltage-gated to some specific issues concerning H fluxes and the Na /K pump, omitting
Load more

Recommended publications
  • Spider-Venom Peptides As Therapeutics
    Toxins 2010, 2, 2851-2871; doi:10.3390/toxins2122851 OPEN ACCESS toxins ISSN 2072-6651 www.mdpi.com/journal/toxins Review Spider-Venom Peptides as Therapeutics Natalie J. Saez, Sebastian Senff, Jonas E. Jensen, Sing Yan Er, Volker Herzig, Lachlan D. Rash and Glenn F. King * Institute for Molecular Bioscience, The University of Queensland, St Lucia, Queensland, 4072, Australia; E-Mails: [email protected] (N.J.S.); [email protected] (S.S.); [email protected] (J.E.J.); [email protected] (S.Y.E.); [email protected] (V.H.); [email protected] (L.D.R.) * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: 61-7-3346-2025; Fax: 61-7-3346-2021. Received: 16 November 2010; in revised form: 17 December 2010 / Accepted: 17 December 2010 / Published: 20 December 2010 Abstract: Spiders are the most successful venomous animals and the most abundant terrestrial predators. Their remarkable success is due in large part to their ingenious exploitation of silk and the evolution of pharmacologically complex venoms that ensure rapid subjugation of prey. Most spider venoms are dominated by disulfide-rich peptides that typically have high affinity and specificity for particular subtypes of ion channels and receptors. Spider venoms are conservatively predicted to contain more than 10 million bioactive peptides, making them a valuable resource for drug discovery. Here we review the structure and pharmacology of spider-venom peptides that are being used as leads for the development of therapeutics against a wide range of pathophysiological conditions including cardiovascular disorders, chronic pain, inflammation, and erectile dysfunction.
    [Show full text]
  • Potent Neuroprotection After Stroke Afforded by a Double-Knot Spider-Venom Peptide That Inhibits Acid-Sensing Ion Channel 1A
    Potent neuroprotection after stroke afforded by a double-knot spider-venom peptide that inhibits acid-sensing ion channel 1a Irène R. Chassagnona, Claudia A. McCarthyb,c, Yanni K.-Y. China, Sandy S. Pinedaa, Angelo Keramidasd, Mehdi Moblie, Vi Phamb,c, T. Michael De Silvab,c, Joseph W. Lynchd, Robert E. Widdopb,c, Lachlan D. Rasha,f,1, and Glenn F. Kinga,1 aInstitute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia; bBiomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia; cDepartment of Pharmacology, Monash University, Clayton, VIC 3800, Australia; dQueensland Brain Institute, The University of Queensland, St. Lucia, QLD 4072, Australia; eCentre for Advanced Imaging, The University of Queensland, St. Lucia, QLD 4072, Australia; and fSchool of Biomedical Sciences, The University of Queensland, St. Lucia, QLD 4072, Australia Edited by Solomon H. Snyder, Johns Hopkins University School of Medicine, Baltimore, MD, and approved February 6, 2017 (received for review September 1, 2016) Stroke is the second-leading cause of death worldwide, yet there are extracellular pH that occurs during cerebral ischemia. ASIC1a is the no drugs available to protect the brain from stroke-induced neuronal primary acid sensor in mammalian brain (9, 10) and a key mediator of injury. Acid-sensing ion channel 1a (ASIC1a) is the primary acid sensor stroke-induced neuronal damage. Genetic ablation of ASIC1a reduces in mammalian brain and a key mediator of acidosis-induced neuronal infarct size by ∼60% after transient middle cerebral artery occlusion damage following cerebral ischemia. Genetic ablation and selective (MCAO) in mice (7), whereas pharmacologic blockade with modestly pharmacologic inhibition of ASIC1a reduces neuronal death follow- potent ASIC1a inhibitors, such as amiloride (7) and nonsteroidal anti- ing ischemic stroke in rodents.
    [Show full text]
  • The Chondrocyte Channelome: a Novel Ion Channel Candidate in the Pathogenesis of Pectus Deformities
    Old Dominion University ODU Digital Commons Biological Sciences Theses & Dissertations Biological Sciences Summer 2017 The Chondrocyte Channelome: A Novel Ion Channel Candidate in the Pathogenesis of Pectus Deformities Anthony J. Asmar Old Dominion University, [email protected] Follow this and additional works at: https://digitalcommons.odu.edu/biology_etds Part of the Biology Commons, Molecular Biology Commons, and the Physiology Commons Recommended Citation Asmar, Anthony J.. "The Chondrocyte Channelome: A Novel Ion Channel Candidate in the Pathogenesis of Pectus Deformities" (2017). Doctor of Philosophy (PhD), Dissertation, Biological Sciences, Old Dominion University, DOI: 10.25777/pyha-7838 https://digitalcommons.odu.edu/biology_etds/19 This Dissertation is brought to you for free and open access by the Biological Sciences at ODU Digital Commons. It has been accepted for inclusion in Biological Sciences Theses & Dissertations by an authorized administrator of ODU Digital Commons. For more information, please contact [email protected]. THE CHONDROCYTE CHANNELOME: A NOVEL ION CHANNEL CANDIDATE IN THE PATHOGENESIS OF PECTUS DEFORMITIES by Anthony J. Asmar B.S. Biology May 2010, Virginia Polytechnic Institute M.S. Biology May 2013, Old Dominion University A Dissertation Submitted to the Faculty of Old Dominion University in Partial Fulfillment of the Requirements for the Degree of DOCTOR OF PHILOSOPHY BIOMEDICAL SCIENCES OLD DOMINION UNIVERSITY August 2017 Approved by: Christopher Osgood (Co-Director) Michael Stacey (Co-Director) Lesley Greene (Member) Andrei Pakhomov (Member) Jing He (Member) ABSTRACT THE CHONDROCYTE CHANNELOME: A NOVEL ION CHANNEL CANDIDATE IN THE PATHOGENESIS OF PECTUS DEFORMITIES Anthony J. Asmar Old Dominion University, 2017 Co-Directors: Dr. Christopher Osgood Dr. Michael Stacey Costal cartilage is a type of rod-like hyaline cartilage connecting the ribs to the sternum.
    [Show full text]
  • Supplementary Table 1. Pain and PTSS Associated Genes (N = 604
    Supplementary Table 1. Pain and PTSS associated genes (n = 604) compiled from three established pain gene databases (PainNetworks,[61] Algynomics,[52] and PainGenes[42]) and one PTSS gene database (PTSDgene[88]). These genes were used in in silico analyses aimed at identifying miRNA that are predicted to preferentially target this list genes vs. a random set of genes (of the same length). ABCC4 ACE2 ACHE ACPP ACSL1 ADAM11 ADAMTS5 ADCY5 ADCYAP1 ADCYAP1R1 ADM ADORA2A ADORA2B ADRA1A ADRA1B ADRA1D ADRA2A ADRA2C ADRB1 ADRB2 ADRB3 ADRBK1 ADRBK2 AGTR2 ALOX12 ANO1 ANO3 APOE APP AQP1 AQP4 ARL5B ARRB1 ARRB2 ASIC1 ASIC2 ATF1 ATF3 ATF6B ATP1A1 ATP1B3 ATP2B1 ATP6V1A ATP6V1B2 ATP6V1G2 AVPR1A AVPR2 BACE1 BAMBI BDKRB2 BDNF BHLHE22 BTG2 CA8 CACNA1A CACNA1B CACNA1C CACNA1E CACNA1G CACNA1H CACNA2D1 CACNA2D2 CACNA2D3 CACNB3 CACNG2 CALB1 CALCRL CALM2 CAMK2A CAMK2B CAMK4 CAT CCK CCKAR CCKBR CCL2 CCL3 CCL4 CCR1 CCR7 CD274 CD38 CD4 CD40 CDH11 CDK5 CDK5R1 CDKN1A CHRM1 CHRM2 CHRM3 CHRM5 CHRNA5 CHRNA7 CHRNB2 CHRNB4 CHUK CLCN6 CLOCK CNGA3 CNR1 COL11A2 COL9A1 COMT COQ10A CPN1 CPS1 CREB1 CRH CRHBP CRHR1 CRHR2 CRIP2 CRYAA CSF2 CSF2RB CSK CSMD1 CSNK1A1 CSNK1E CTSB CTSS CX3CL1 CXCL5 CXCR3 CXCR4 CYBB CYP19A1 CYP2D6 CYP3A4 DAB1 DAO DBH DBI DICER1 DISC1 DLG2 DLG4 DPCR1 DPP4 DRD1 DRD2 DRD3 DRD4 DRGX DTNBP1 DUSP6 ECE2 EDN1 EDNRA EDNRB EFNB1 EFNB2 EGF EGFR EGR1 EGR3 ENPP2 EPB41L2 EPHB1 EPHB2 EPHB3 EPHB4 EPHB6 EPHX2 ERBB2 ERBB4 EREG ESR1 ESR2 ETV1 EZR F2R F2RL1 F2RL2 FAAH FAM19A4 FGF2 FKBP5 FLOT1 FMR1 FOS FOSB FOSL2 FOXN1 FRMPD4 FSTL1 FYN GABARAPL1 GABBR1 GABBR2 GABRA2 GABRA4
    [Show full text]
  • ION CHANNELS S72 Acid-Sensing (Proton-Gated) Ion Channels (Asics) Alexander Et Al
    ION CHANNELS S72 Acid-sensing (proton-gated) ion channels (ASICs) Alexander et al Acid-sensing (proton-gated) ion channels (ASICs) Overview: Acid-sensing ion channels (ASICs, provisional nomenclature) are members of a Na þ channel superfamily that includes the epithelial Na channel, ENaC, the FMRF-amide activated channel of Helix aspersa, the degenerins (DEG) of Caenorhabitis elegans (see Waldmann & Lazdunski, 1998; Mano & Discoll, 1999) and ‘orphan’ channels that include BLINaC (Sakai et al., 1999) and INaC (Schaefer et al., 2000). ASIC subunits contain two putative TM domains and assemble as homo- or heterotetramers to form proton-gated, Na þ permeable channels. Splice variants of ASIC1 (provisionally termed ASIC1a (ASIC-a) (Waldmann et al., 1997a) and ASIC1b (ASIC-b) (Chen et al., 1998)) and ASIC2 (provisionally termed ASIC2a (MDEG1) and ASIC2b (MDEG2); Lingueglia et al., 1997) have been cloned. Unlike ASIC2a (listed in table), heterologous expression of ASIC2b alone does not support H þ -gated currents. Transcripts encoding a fourth member of the ASIC family (ASIC4/SPASIC) do not produce a proton-gated channel in heterologous expression systems (Akopian et al., 2000; Grunder et al., 2000). ASIC channels are expressed in central and peripheral neurons and particularly in nociceptors where they participate in neuronal sensitivity to acidosis. The relationship of the cloned ASICs to endogenously expressed proton-gated ion channels is becoming established (Escoubas et al., 2000; Sutherland et al., 2001; Wemmie et al., 2002; 2003). Heterologously expressed heteromutimers of ASIC1/ASIC2a, ASIC2a/ASIC2b, ASIC2a/ASIC3 ASIC2b/ASIC3 and ASIC1a/ASIC3 form ion channels with altered kinetics, ion selectivity, pH-sensitivity and sensitivity to block by Gd3 þ (Bassilana et al., 1997; Lingueglia et al., 1997; Babinski et al., 2000; Escoubas et al., 2000).
    [Show full text]
  • On Obtaining Estimates of Parent-Of-Origin Effects Effectively and Their Exploitation in Association Genetic Mapping
    Aus dem Leibniz-Institut für Nutztierbiologie (FBN) Institut für Genetik und Biometrie Dummerstorf ON OBTAINING ESTIMATES OF PARENT-OF-ORIGIN EFFECTS EFFECTIVELY AND THEIR EXPLOITATION IN ASSOCIATION GENETIC MAPPING Dissertation zur Erlangung des Doktorgrades der Agrar- und Ernährungswissenschaftlichen Fakultät der Christian-Albrechts-Universität zu Kiel vorgelegt von M.Sc. agr. Inga Blunk aus Bad Segeberg, Schleswig-Holstein Dekan: Prof. Dr. Joachim Krieter 1. Berichterstatter: Prof. Dr. Norbert Reinsch 2. Berichterstatter: Prof. Dr. Georg Thaller Tag der mündlichen Prüfung: 6. November 2017 Die Dissertation wurde mit dankenswerter finanzieller Unterstützung der H. Wilhelm Schaumann Stiftung, Hamburg, angefertigt. „Das Schönste, was wir erleben können, ist das Geheimnisvolle. …“ ALBERT EINSTEIN TABLE OF CONTENTS General Introduction ………………………………………………………………………. 1 Chapter 1 ………………………………………………………………………………..…… 12 Genetic variance components when fluctuating imprinting patterns are present Chapter 2 ………………………………………………………………………………..…… 21 A new model for parent-of-origin effect analyses applied to Brown Swiss cattle slaughterhouse data Chapter 3 ………………………………………………………………………………..…… 46 Parsimonious model for analyzing parent-of-origin effects related to beef traits in dual-purpose Simmental Chapter 4 ……………………………………………………………………………………. 72 Scanning the genomes of parents for imprinted loci acting in their ungenotyped progeny General Discussion ………………………………………………………………………. 113 Summary ……………………………………………………………………………………. 123 Zusammenfassung ……………………………………………………………………….
    [Show full text]
  • Transcriptomic Profiling of Ca Transport Systems During
    cells Article Transcriptomic Profiling of Ca2+ Transport Systems during the Formation of the Cerebral Cortex in Mice Alexandre Bouron Genetics and Chemogenomics Lab, Université Grenoble Alpes, CNRS, CEA, INSERM, Bâtiment C3, 17 rue des Martyrs, 38054 Grenoble, France; [email protected] Received: 29 June 2020; Accepted: 24 July 2020; Published: 29 July 2020 Abstract: Cytosolic calcium (Ca2+) transients control key neural processes, including neurogenesis, migration, the polarization and growth of neurons, and the establishment and maintenance of synaptic connections. They are thus involved in the development and formation of the neural system. In this study, a publicly available whole transcriptome sequencing (RNA-Seq) dataset was used to examine the expression of genes coding for putative plasma membrane and organellar Ca2+-transporting proteins (channels, pumps, exchangers, and transporters) during the formation of the cerebral cortex in mice. Four ages were considered: embryonic days 11 (E11), 13 (E13), and 17 (E17), and post-natal day 1 (PN1). This transcriptomic profiling was also combined with live-cell Ca2+ imaging recordings to assess the presence of functional Ca2+ transport systems in E13 neurons. The most important Ca2+ routes of the cortical wall at the onset of corticogenesis (E11–E13) were TACAN, GluK5, nAChR β2, Cav3.1, Orai3, transient receptor potential cation channel subfamily M member 7 (TRPM7) non-mitochondrial Na+/Ca2+ exchanger 2 (NCX2), and the connexins CX43/CX45/CX37. Hence, transient receptor potential cation channel mucolipin subfamily member 1 (TRPML1), transmembrane protein 165 (TMEM165), and Ca2+ “leak” channels are prominent intracellular Ca2+ pathways. The Ca2+ pumps sarco/endoplasmic reticulum Ca2+ ATPase 2 (SERCA2) and plasma membrane Ca2+ ATPase 1 (PMCA1) control the resting basal Ca2+ levels.
    [Show full text]
  • Pain Research Product Guide | Edition 2
    Pain Research Product Guide | Edition 2 Chili plant Capsicum annuum A source of Capsaicin Contents by Research Area: • Nociception • Ion Channels • G-Protein-Coupled Receptors • Intracellular Signaling Tocris Product Guide Series Pain Research Contents Page Nociception 3 Ion Channels 4 G-Protein-Coupled Receptors 12 Intracellular Signaling 18 List of Acronyms 21 Related Literature 22 Pain Research Products 23 Further Reading 34 Introduction Pain is a major public health problem with studies suggesting one fifth of the general population in both the USA and Europe are affected by long term pain. The International Association for the Study of Pain (IASP) defines pain as ‘an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage’. Management of chronic pain in the clinic has seen only limited progress in recent decades. Treatment of pain has been reliant on, and is still dominated by two classical medications: opioids and non-steroidal anti-inflammatory drugs (NSAIDs). However, side effects such as dependence associated with opioids and gastric ulceration associated with NSAIDs demonstrates the need for new drug targets and novel compounds that will bring in a new era of pain therapeutics. Pain has been classified into three major types: nociceptive pain, inflammatory pain and neuropathic or pathological pain. Nociceptive pain involves the transduction of painful stimuli by peripheral sensory nerve fibers called nociceptors. Neuropathic pain results from damage or disease affecting the sensory system, and inflammatory pain represents the immunological response to injury through inflammatory mediators that contribute to pain. Our latest pain research guide focuses on nociception and the transduction of pain to the spinal cord, examining some of the main classical targets as well as emerging pain targets.
    [Show full text]
  • Multiple Modulation of Acid-Sensing Ion Channel 1A by the Alkaloid Daurisoline
    biomolecules Article Multiple Modulation of Acid-Sensing Ion Channel 1a by the Alkaloid Daurisoline Dmitry I. Osmakov 1,2,* , Sergey G. Koshelev 1, Ekaterina N. Lyukmanova 1, Mikhail A. Shulepko 1, Yaroslav A. Andreev 1,2, Peter Illes 3 and Sergey A. Kozlov 1 1 Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, ul. Miklukho-Maklaya 16/10, 117997 Moscow, Russia 2 Institute of Molecular Medicine, Sechenov First Moscow State Medical University, Trubetskaya str. 8, bld. 2, 119991 Moscow, Russia 3 Rudolf-Boehm-Institut für Pharmakologie und Toxikologie, University of Leipzig, 04107 Leipzig, Germany * Correspondence: [email protected] Received: 26 June 2019; Accepted: 1 August 2019; Published: 2 August 2019 Abstract: Acid-sensing ion channels (ASICs) are proton-gated sodium-selective channels that are expressed in the peripheral and central nervous systems. ASIC1a is one of the most intensively studied isoforms due to its importance and wide representation in organisms, but it is still largely unexplored as a target for therapy. In this study, we demonstrated response of the ASIC1a to acidification in the presence of the daurisoline (DAU) ligand. DAU alone did not activate the channel, but in combination with protons, it produced the second peak component of the ASIC1a current. This second peak differs from the sustained component (which is induced by RF-amide peptides), as the second (DAU-induced) peak is completely desensitized, with the same kinetics as the main peak. The co-application of DAU and mambalgin-2 indicated that their binding sites do not overlap. Additionally,we found an asymmetry in the pH activation curve of the channel, which was well-described by a mathematical model based on the multiplied probabilities of protons binding with a pool of high-cooperative sites and a single proton binding with a non-cooperative site.
    [Show full text]
  • Ion Channels
    UC Davis UC Davis Previously Published Works Title THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Ion channels. Permalink https://escholarship.org/uc/item/1442g5hg Journal British journal of pharmacology, 176 Suppl 1(S1) ISSN 0007-1188 Authors Alexander, Stephen PH Mathie, Alistair Peters, John A et al. Publication Date 2019-12-01 DOI 10.1111/bph.14749 License https://creativecommons.org/licenses/by/4.0/ 4.0 Peer reviewed eScholarship.org Powered by the California Digital Library University of California S.P.H. Alexander et al. The Concise Guide to PHARMACOLOGY 2019/20: Ion channels. British Journal of Pharmacology (2019) 176, S142–S228 THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Ion channels Stephen PH Alexander1 , Alistair Mathie2 ,JohnAPeters3 , Emma L Veale2 , Jörg Striessnig4 , Eamonn Kelly5, Jane F Armstrong6 , Elena Faccenda6 ,SimonDHarding6 ,AdamJPawson6 , Joanna L Sharman6 , Christopher Southan6 , Jamie A Davies6 and CGTP Collaborators 1School of Life Sciences, University of Nottingham Medical School, Nottingham, NG7 2UH, UK 2Medway School of Pharmacy, The Universities of Greenwich and Kent at Medway, Anson Building, Central Avenue, Chatham Maritime, Chatham, Kent, ME4 4TB, UK 3Neuroscience Division, Medical Education Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee, DD1 9SY, UK 4Pharmacology and Toxicology, Institute of Pharmacy, University of Innsbruck, A-6020 Innsbruck, Austria 5School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, BS8 1TD, UK 6Centre for Discovery Brain Science, University of Edinburgh, Edinburgh, EH8 9XD, UK Abstract The Concise Guide to PHARMACOLOGY 2019/20 is the fourth in this series of biennial publications. The Concise Guide provides concise overviews of the key properties of nearly 1800 human drug targets with an emphasis on selective pharmacology (where available), plus links to the open access knowledgebase source of drug targets and their ligands (www.guidetopharmacology.org), which provides more detailed views of target and ligand properties.
    [Show full text]
  • Trypsin-Like Proteases and Their Role in Muco-Obstructive Lung Diseases
    International Journal of Molecular Sciences Review Trypsin-Like Proteases and Their Role in Muco-Obstructive Lung Diseases Emma L. Carroll 1,†, Mariarca Bailo 2,†, James A. Reihill 1 , Anne Crilly 2 , John C. Lockhart 2, Gary J. Litherland 2, Fionnuala T. Lundy 3 , Lorcan P. McGarvey 3, Mark A. Hollywood 4 and S. Lorraine Martin 1,* 1 School of Pharmacy, Queen’s University, Belfast BT9 7BL, UK; [email protected] (E.L.C.); [email protected] (J.A.R.) 2 Institute for Biomedical and Environmental Health Research, School of Health and Life Sciences, University of the West of Scotland, Paisley PA1 2BE, UK; [email protected] (M.B.); [email protected] (A.C.); [email protected] (J.C.L.); [email protected] (G.J.L.) 3 Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen’s University, Belfast BT9 7BL, UK; [email protected] (F.T.L.); [email protected] (L.P.M.) 4 Smooth Muscle Research Centre, Dundalk Institute of Technology, A91 HRK2 Dundalk, Ireland; [email protected] * Correspondence: [email protected] † These authors contributed equally to this work. Abstract: Trypsin-like proteases (TLPs) belong to a family of serine enzymes with primary substrate specificities for the basic residues, lysine and arginine, in the P1 position. Whilst initially perceived as soluble enzymes that are extracellularly secreted, a number of novel TLPs that are anchored in the cell membrane have since been discovered. Muco-obstructive lung diseases (MucOLDs) are Citation: Carroll, E.L.; Bailo, M.; characterised by the accumulation of hyper-concentrated mucus in the small airways, leading to Reihill, J.A.; Crilly, A.; Lockhart, J.C.; Litherland, G.J.; Lundy, F.T.; persistent inflammation, infection and dysregulated protease activity.
    [Show full text]
  • A Novel Role for TRPM8 in Visceral Afferent Function
    PAINÒ 152 (2011) 1459–1468 www.elsevier.com/locate/pain Research papers A novel role for TRPM8 in visceral afferent function ⇑ Andrea M. Harrington a,b, , Patrick A. Hughes a,b, Christopher M. Martin a, Jing Yang a,b, Joel Castro a, Nicole J. Isaacs a, L. Ashley Blackshaw a,b,c, Stuart M. Brierley a,b,c a Nerve-Gut Research Laboratory, Department of Gastroenterology & Hepatology, Hanson Institute, Royal Adelaide Hospital, Adelaide, South Australia, Australia b Discipline of Medicine, University of Adelaide, Adelaide, South Australia, Australia c Discipline of Physiology, University of Adelaide, Adelaide, South Australia, Australia Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article. article info abstract Article history: Transient receptor potential ion channel melastatin subtype 8 (TRPM8) is activated by cold temperatures Received 15 July 2010 and cooling agents, such as menthol and icilin. Compounds containing peppermint are reported to reduce Received in revised form 24 November 2010 symptoms of bowel hypersensitivity; however, the underlying mechanisms of action are unclear. Here Accepted 14 January 2011 we determined the role of TRPM8 in colonic sensory pathways. Laser capture microdissection, quantita- tive reverse transcription-polymerase chain reaction (RT-PCR), immunofluorescence, and retrograde trac- ing were used to localise TRPM8 to colonic primary afferent neurons. In vitro extracellular single-fibre Keywords: afferent recordings were used to determine the effect of TRPM8 channel activation on the chemosensory Transient receptor potential ion channel and mechanosensory function of colonic high-threshold afferent fibres. TRPM8 mRNA was present in melastatin 8 Mechanosensation colonic DRG neurons, whereas TRPM8 protein was present on nerve fibres throughout the wall of the Chemosensation colon.
    [Show full text]